These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 31677793)
1. Xylosyltransferase-deficient human HEK293 cells show a strongly reduced proliferation capacity and viability. Fischer B; Ly TD; Schmidt V; Hendig D; Kuhn J; Knabbe C; Faust I Biochem Biophys Res Commun; 2020 Jan; 521(2):507-513. PubMed ID: 31677793 [TBL] [Abstract][Full Text] [Related]
2. First Characterization of Human Dermal Fibroblasts Showing a Decreased Xylosyltransferase-I Expression Induced by the CRISPR/Cas9 System. Fischer B; Schmidt V; Ly TD; Kleine A; Knabbe C; Faust-Hinse I Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563435 [TBL] [Abstract][Full Text] [Related]
3. Development of a xylosyltransferase-I-selective UPLC MS/MS activity assay using a specific acceptor peptide. Fischer B; Kuhn J; Ly TD; Schmidt V; Kleine A; Hendig D; Knabbe C; Faust I Biochimie; 2021 May; 184():88-94. PubMed ID: 33609631 [TBL] [Abstract][Full Text] [Related]
4. Xylosyltransferase-Deficiency in Human Dermal Fibroblasts Induces Compensatory Myofibroblast Differentiation and Long-Term ECM Reduction. Kleine A; Kühle M; Ly TD; Schmidt V; Faust-Hinse I; Knabbe C; Fischer B Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540185 [TBL] [Abstract][Full Text] [Related]
5. Human xylosyltransferases in health and disease. Götting C; Kuhn J; Kleesiek K Cell Mol Life Sci; 2007 Jun; 64(12):1498-517. PubMed ID: 17437056 [TBL] [Abstract][Full Text] [Related]
6. Activin A-Mediated Regulation of XT-I in Human Skin Fibroblasts. Ly TD; Plümers R; Fischer B; Schmidt V; Hendig D; Kuhn J; Knabbe C; Faust I Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32295230 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of human xylosyltransferase II promoter single nucleotide variants. Faust I; Böker KO; Eirich C; Akkermann D; Kuhn J; Knabbe C; Hendig D Biochem Biophys Res Commun; 2015 Mar; 458(4):901-7. PubMed ID: 25704086 [TBL] [Abstract][Full Text] [Related]
8. Human Xylosyltransferase I-An Important Linker between Acute Senescence and Fibrogenesis. Schmidt V; Ohmes J; Ly TD; Fischer B; Kleine A; Knabbe C; Faust-Hinse I Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36830996 [TBL] [Abstract][Full Text] [Related]
9. A novel SPE-UPLC-MS/MS-based assay for the selective, simultaneous quantification of xylosyltransferase-I and -II activity. Kleine A; Kühle M; Kuhn J; Ly TD; Schmidt V; Faust-Hinse I; Knabbe C; Fischer B Biochimie; 2024 Mar; 218():127-136. PubMed ID: 37689257 [TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. Götting C; Kuhn J; Zahn R; Brinkmann T; Kleesiek K J Mol Biol; 2000 Dec; 304(4):517-28. PubMed ID: 11099377 [TBL] [Abstract][Full Text] [Related]
11. Differences in gene expression of human xylosyltransferases and determination of acceptor specificities for various proteoglycans. Roch C; Kuhn J; Kleesiek K; Götting C Biochem Biophys Res Commun; 2010 Jan; 391(1):685-91. PubMed ID: 19944077 [TBL] [Abstract][Full Text] [Related]
13. Heterologous expression and biochemical characterization of soluble human xylosyltransferase II. Casanova JC; Kuhn J; Kleesiek K; Götting C Biochem Biophys Res Commun; 2008 Jan; 365(4):678-84. PubMed ID: 18023272 [TBL] [Abstract][Full Text] [Related]
14. First description of a compensatory xylosyltransferase I induction observed after an antifibrotic UDP-treatment of normal human dermal fibroblasts. Fischer B; Ly TD; Hendig D; Kuhn J; Pécheur EI; Reungoat E; Knabbe C; Faust I Biochem Biophys Res Commun; 2019 Apr; 512(1):7-13. PubMed ID: 30853184 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course. Schön S; Schulz V; Prante C; Hendig D; Szliska C; Kuhn J; Kleesiek K; Götting C J Med Genet; 2006 Sep; 43(9):745-9. PubMed ID: 16571645 [TBL] [Abstract][Full Text] [Related]
16. Cloning and recombinant expression of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II. Schön S; Prante C; Bahr C; Kuhn J; Kleesiek K; Götting C J Biol Chem; 2006 May; 281(20):14224-31. PubMed ID: 16569644 [TBL] [Abstract][Full Text] [Related]
17. The formation of extracellular matrix during chondrogenic differentiation of mesenchymal stem cells correlates with increased levels of xylosyltransferase I. Prante C; Bieback K; Funke C; Schön S; Kern S; Kuhn J; Gastens M; Kleesiek K; Götting C Stem Cells; 2006 Oct; 24(10):2252-61. PubMed ID: 16778156 [TBL] [Abstract][Full Text] [Related]
18. Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum. Kuhn J; Götting C; Beahm BJ; Bertozzi CR; Faust I; Kuzaj P; Knabbe C; Hendig D Biochem Biophys Res Commun; 2015 Apr; 459(3):469-74. PubMed ID: 25748573 [TBL] [Abstract][Full Text] [Related]
19. XT-II, the second isoform of human peptide-O-xylosyltransferase, displays enzymatic activity. Voglmeir J; Voglauer R; Wilson IB J Biol Chem; 2007 Mar; 282(9):5984-90. PubMed ID: 17194707 [TBL] [Abstract][Full Text] [Related]
20. Mutational and functional analyses of xylosyltransferases and their implication in osteoarthritis. Schön S; Huep G; Prante C; Müller S; Christ R; Hagena FW; Kuhn J; Kleesiek K; Götting C Osteoarthritis Cartilage; 2006 May; 14(5):442-8. PubMed ID: 16376579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]